skeleton
short femur
(
J:191061
)
• slightly shortened
|
• reduced osteoclast surface/bone surface ratio
|
• RANKL and Trem2 induced in vitro osteoclastogenesis is completely abrogated
|
• in femora and proximal tibia
|
• in femora and proximal tibia
|
• femora display osteopetrosis
|
immune system
• reduced osteoclast surface/bone surface ratio
|
• RANKL and Trem2 induced in vitro osteoclastogenesis is completely abrogated
|
• impaired apoptosis
• 50% reduction of neutrophil extracellular trap formation in response to either Staphylococcus aureus or Candida albicans infection
• 50% reduction in superoxide production in response to zymosan and curdlan
• extracellular bacterial killing is significantly decreased
|
• susceptibility to Staphylococcus aureus infection is considerably increased
|
• susceptibility to Candida albicans infection is slightly increased
|
limbs/digits/tail
short femur
(
J:191061
)
• slightly shortened
|
hematopoietic system
• reduced osteoclast surface/bone surface ratio
|
• RANKL and Trem2 induced in vitro osteoclastogenesis is completely abrogated
|
• impaired apoptosis
• 50% reduction of neutrophil extracellular trap formation in response to either Staphylococcus aureus or Candida albicans infection
• 50% reduction in superoxide production in response to zymosan and curdlan
• extracellular bacterial killing is significantly decreased
|
cellular
• RANKL and Trem2 induced in vitro osteoclastogenesis is completely abrogated
|